Support Services Fees. For the services provided by A5 under Section 3 (the “A5 Services”), Atossa will pay A5 a service fee equal to US$65 for each NextCYTE Test for which A5 Services are provided; provided, however, that no such fee shall be due for NextCYTE Tests performed during the validation and pre-commercial launch periods. The service fees shall be paid quarterly in arrears within 30 days after the end of each calendar quarter.
Appears in 2 contracts
Sources: License and Services Agreement (Atossa Genetics Inc), License and Services Agreement (Atossa Genetics Inc)